Vanguard Global Advisers’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Sell
12,301
-50
-0.4% -$7.42K ﹤0.01% 1158
2026
Q1
$1.15M Buy
+12,351
New +$1.09M ﹤0.01% 1564

Other funds holding ACLS

Vanguard Global Advisers's ACLS Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Axcelis (ACLS) stake by 0.4% in Q2 2026, selling an estimated $7.42K and leaving 12,301 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Vanguard Global Advisers first reported a position in ACLS in Q1 2026 and has held it in 2 quarters since. 432 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Vanguard Global Advisers held 12,301 shares of Axcelis worth $2.33M as of Q2 2026.
  • Vanguard Global Advisers sold 50 Axcelis shares in Q2 2026, an estimated $7.42K.
  • Axcelis made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1158 holding.
  • Vanguard Global Advisers first reported a position in Axcelis in Q1 2026 and has held it in 2 quarters since.
  • 432 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.